TELADOC HEALTH INC (TDOC) Stock News
NYSE:TDOC - New York Stock Exchange, Inc. - US87918A1051 - Common Stock - Currency: USD
TDOC Latest News, Press Relases and Analysis
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued...
Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates
Teladoc (TDOC) delivered earnings and revenue surprises of 42.42% and 1.89%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MODV
Teladoc Health Stock Slides On Q1 Earnings As Company Cuts FY25 Guidance
Teladoc reports first-quarter revenue of $629.4 million, beating the consensus estimate of $619.29 million, according to Benzinga Pro.
Teladoc stock forms a giant double bottom: will it rise after earnings?
Teladoc stock price continues to crash and is hovering at its lowest level on record ahead of its first-quarter earnings
Teladoc (TDOC) Stock Sinks As Market Gains: Here's Why
Teladoc (TDOC) concluded the recent trading session at $7.20, signifying a -0.83% move from its prior day's close.
Teladoc’s (NYSE:TDOC) Q1 Sales Beat Estimates
Digital medical services platform Teladoc Health (NYSE:TDOC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 2.6% year on year to $629.4 million. The company expects next quarter’s revenue to be around $623.5 million, close to analysts’ estimates. Its GAAP loss of $0.53 per share was 57.8% below analysts’ consensus estimates.
Teladoc Health Reports First Quarter 2025 Results
Teladoc Health Reports First Quarter 2025 Results
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results...
Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits
Acquisition Broadens Access to Virtual Mental Health Services with In-Network Health Plan Relationships Representing More Than 100 Million Covered Lives
Teladoc Health Acquires UpLift, Expanding Consumer Access to Mental Health Care Services Through Covered Benefits
Teladoc Health has acquired UpLift, a virtual mental health provider with in-network health plan relationships representing more than 100M covered lives....
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment? Let's see.
Mentions: HIMS
Teladoc (TDOC) Reports Earnings Tomorrow: What To Expect
Digital medical services platform Teladoc Health (NYSE:TDOC) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Unveiling Teladoc (TDOC) Q1 Outlook: Wall Street Estimates for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Teladoc (TDOC), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Teladoc Health to Announce First Quarter 2025 Financial Results
Teladoc Health to Announce First Quarter 2025 Financial Results
PURCHASE, NY, April 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release...
Hims & Hers Health, Inc. (HIMS): A Bull Case Theory
We came across a bullish thesis on Hims & Hers Health, Inc. (HIMS) on wallstreetbets Subreddit Page by MostCapital5741. In this article, we will summarize the bulls’ thesis on HIMS. Hims & Hers Health, Inc. (HIMS)’s share was trading at $29.46 as of April 15th. HIMS’s trailing and forward P/E were 55.58 and 49.51 respectively according to […]
Why Empire Petroleum Corporation (EP) Stock is Gaining This Week
We recently compiled a list of the Energy Stocks that are Gaining This Week. In this article, we are going to take a look at where Empire Petroleum Corporation (NYSE:EP) stands against the other energy stocks. The energy industry has found itself right in the crosshairs of President Trump’s tariff war, sliding more than 8% over the […]
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. Let's consider two examples: Teladoc Health (NYSE: TDOC) and Tandem Diabetes Care (NASDAQ: TNDM). Teladoc Health, a telemedicine specialist, might not feel a substantial direct impact from Trump's tariffs.
Mentions: TNDM
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
Mentions: TNDM
When It’s Safe — or Not — To Share Your Banking Info
Have you ever been asked for your checking account number or bank's routing number? Maybe it was for a wire transfer or to set up direct deposit. Whatever the case, it's generally okay to share your...
Why Alignment Healthcare Inc. (ALHC) Surged On Tuesday?
We recently published a list of 10 Stocks Lead Rally Amid Market Bloodbath. In this article, we are going to take a look at where Alignment Healthcare Inc. (NASDAQ:ALHC) stands against other stocks that lead rally amid market bloodbath. The stock market took a battering anew on Tuesday, with all major indices registering steep losses […]
Teladoc Health Introduces Next Generation Cardiometabolic Health Program
New resources aim to improve population health and prevent the progression of diabetes, hypertension and obesity
Teladoc Health Introduces Next Generation Cardiometabolic Health Program
Teladoc Health's new offering is designed to support optimal cardiometabolic health for all populations and prevent the progression of disease....
Hims Stock Rockets After Inking Deal To Sell Eli Lilly's Obesity Drug, Zepbound
The deal allows Hims & Hers to sell Eli Lilly's Zepbound on its telehealth platform.
Should Investors Buy These 2 Beaten-Down Artificial Intelligence (AI) Healthcare Stocks?
Artificial intelligence (AI) is changing the world. Corporations are racing to establish themselves as leaders in the field, while investors want to cash in by putting their hard-earned money into the most promising AI companies. Two AI healthcare stocks -- Recursion Pharmaceuticals (NASDAQ: RXRX) and Teladoc Health (NYSE: TDOC) -- have lagged the market over the past year.
Mentions: RXRX